Similar articles

• [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].

  Peter JD, Jehl F, Froehly S, Dupeyron JP, Monteil H, Rosset MA. Peter JD, et al. Pathol Biol (Paris). 1988 May;36(5):525-30. Pathol Biol (Paris). 1988. PMID: 3043352 French.
• Isolated bacteria and susceptibilities to antimicrobial agents in biliary infections.

  Mukaiya M, Hirata K, Katsuramaki T, Kihara C, Kimura Y, Yamaguchi K, Furuhata T, Hata F. Mukaiya M, et al. Hepatogastroenterology. 2005 May-Jun;52(63):686-90. Hepatogastroenterology. 2005. PMID: 15966183
• [Aztreonam in infections caused by gram-negative aerobic bacilli].

  Rodríguez French A, Kenion G, Rodríguez C. Rodríguez French A, et al. Rev Med Panama. 1988 Jan;13(1):4-8. Rev Med Panama. 1988. PMID: 3347772 Spanish. No abstract available.
• Aztreonam: a narrow spectrum against gram-negative aerobes.

  [No authors listed] [No authors listed] Drug Ther Bull. 1987 Nov 2;25(22):86-8. Drug Ther Bull. 1987. PMID: 3315541 Review. No abstract available.
• [Antibiotics in the treatment of biliary tract infections].

  Perkowski H. Perkowski H. Wiad Lek. 1989 Jan 15;42(2):101-5. Wiad Lek. 1989. PMID: 2683383 Review. Polish.